These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8848219)

  • 21. [Experimental models of multiple sclerosis].
    Sierakowski SJ; Kucharz EJ
    Postepy Hig Med Dosw; 1988; 42(6):619-40. PubMed ID: 3076656
    [No Abstract]   [Full Text] [Related]  

  • 22. Antinuclear antibodies in progressive systemic sclerosis.
    Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
    Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study].
    Martínez-Cordero E; Burgos-Vargas R; Herrera-Esparza R; Reyes PA
    Rev Invest Clin; 1983; 35(4):273-7. PubMed ID: 6369466
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical variant of lupus erythematosus resembling multiple sclerosis.
    Cendrowski W; Stepień M
    Eur Neurol; 1974; 11(6):373-6. PubMed ID: 4546756
    [No Abstract]   [Full Text] [Related]  

  • 25. Antinuclear antibodies associated with pulmonary involvement in systemic sclerosis.
    Martinez-Cordero E
    Chest; 1989 Oct; 96(4):960-1. PubMed ID: 2791706
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antinuclear antibodies in sarcoidosis].
    de la Figuera M; Sanjuas C; Vilardell M; Morera J; Marquet R; del Mar Villar M
    Med Clin (Barc); 1983 Dec; 81(19):878-9. PubMed ID: 6606750
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antinuclear antibodies in progressive systemic sclerosis].
    Sepúlveda C; Palma S; Guzmán L; Bravo M
    Rev Med Chil; 1986 Aug; 114(8):731-6. PubMed ID: 3554436
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of antinuclear antibodies in a normal male population.
    White GL; Wood SD; Rom WN
    Mil Med; 1983 Jun; 148(6):536-8. PubMed ID: 6412171
    [No Abstract]   [Full Text] [Related]  

  • 29. High prevalence of antinuclear antibodies in sandblasters' silicosis.
    Jones RN; Turner-Warwick M; Ziskind M; Weill H
    Am Rev Respir Dis; 1976 Mar; 113(3):393-5. PubMed ID: 1083176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antinuclear antibodies in patients with systemic scleroderma].
    Wranicz A; Defecińska-Trzeciak E
    Przegl Dermatol; 1972; 59(3):315-20. PubMed ID: 4538127
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antinuclear antibodies in the blood of patients with otosclerosis].
    Jesić S; Savić D; Mircetić B; Djerić D
    Srp Arh Celok Lek; 1986 Jan; 114(1):91-7. PubMed ID: 3487838
    [No Abstract]   [Full Text] [Related]  

  • 32. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment.
    Johnstone EC; Whaley K
    Br Med J; 1975 Jun; 2(5973):724-5. PubMed ID: 1079738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.
    Wu L; Huang D; Yang Y; Wu W
    Eur Neurol; 2014; 72(1-2):103-8. PubMed ID: 24993096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rheumatoid arthritis with antinuclear antibodies in the blood].
    Pelísková Z; Trnavský K; Vácha J
    Vnitr Lek; 1985 Aug; 31(8):756-61. PubMed ID: 3875927
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antinuclear antibodies and PUVA therapy].
    Cattaneo R; Pancera C; Fenini MG; Gavazzoni R; De Costanza F
    G Ital Dermatol Venereol; 1982; 117(4):207-10. PubMed ID: 6985322
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antinuclear factors in patients with pancreatitis of unknown aetiology: A pointer to an immunopathological cause? (Author's transl)].
    Neher M; Lemmel EM
    Dtsch Med Wochenschr; 1975 Feb; 100(8):362-7. PubMed ID: 1090429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.
    Roussel V; Yi F; Jauberteau MO; Couderq C; Lacombe C; Michelet V; Gil R; Couratier P; Vallat JM; Preud'homme JL
    J Autoimmun; 2000 May; 14(3):259-65. PubMed ID: 10756088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of antinuclear antibodies in hypertensive diabetics treated with acebutolol].
    Leblanc H; Lombrail P; Marre M; Abadie E; Passa P
    Presse Med; 1984 Dec; 13(45):2747-9. PubMed ID: 6240046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies and response to IFNbeta-1a therapy in relapsing-remitting multiple sclerosis.
    Ciccarelli O; Bagnato F; Mainero C; Salvetti M; Paolillo A; Gasperini C; Bastianello S; Pozzilli C
    Mult Scler; 2000 Jun; 6(3):137-9. PubMed ID: 10871823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antinuclear antibodies in patients with rheumatoid arthritis].
    Wranicz A; Budźko T
    Pol Tyg Lek; 1970 Oct; 25(42):1570-3. PubMed ID: 4920352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.